{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T12:45:06Z","timestamp":1788871506301,"version":"build-2803163510"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes for Health Research","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003579","name":"University of Toronto","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003579","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Lunenfeld-Tanenbaum Research Institute"},{"name":"Ontario Graduate Scholarship fund"},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes for Health Research","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["thebonejournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bone"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1016\/j.bone.2014.07.037","type":"journal-article","created":{"date-parts":[[2014,8,8]],"date-time":"2014-08-08T08:30:59Z","timestamp":1407486659000},"page":"57-66","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Development, validation and characterization of a novel mouse model of Adynamic Bone Disease (ABD)"],"prefix":"10.1016","volume":"68","author":[{"given":"Adeline H.","family":"Ng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas L.","family":"Willett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin A.","family":"Alman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc D.","family":"Grynpas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bone.2014.07.037_bb0005","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM198209163071202","article-title":"The prevalence of bone aluminum deposition in renal osteodystrophy and its relation to the response to calcitriol therapy","volume":"307","author":"Ott","year":"1982","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bone.2014.07.037_bb0010","first-page":"S87","article-title":"Parathyroid hormone in aluminum bone disease: a comparison of parathyroid hormone assays","volume":"18","author":"Andress","year":"1986","journal-title":"Kidney Int Suppl"},{"key":"10.1016\/j.bone.2014.07.037_bb0015","series-title":"Atlas of mineralized bone histology","author":"Malluche","year":"1986"},{"key":"10.1016\/j.bone.2014.07.037_bb0020","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/ki.1993.64","article-title":"The spectrum of bone disease in end-stage renal failure\u2014an evolving disorder","volume":"43","author":"Sherrard","year":"1993","journal-title":"Kidney Int"},{"issue":"Suppl. 1","key":"10.1016\/j.bone.2014.07.037_bb0025","doi-asserted-by":"crossref","first-page":"i9","DOI":"10.1093\/ndt\/gfh1002","article-title":"The importance of bone health in end-stage renal disease: out of the frying pan, into the fire?","volume":"19","author":"Malluche","year":"2004","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.bone.2014.07.037_bb0030","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1038\/ki.2008.60","article-title":"Adynamic bone in patients with chronic kidney disease","volume":"73","author":"Andress","year":"2008","journal-title":"Kidney Int"},{"key":"10.1016\/j.bone.2014.07.037_bb0035","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1093\/ndtplus\/sfn040","article-title":"Adynamic bone disease\u2014bone and beyond","volume":"1","author":"Brandenburg","year":"2008","journal-title":"NDT Plus"},{"key":"10.1016\/j.bone.2014.07.037_bb0040","first-page":"117","article-title":"Adynamic bone disease: an update and overview","volume":"18","author":"Coen","year":"2005","journal-title":"J Nephrol"},{"key":"10.1016\/j.bone.2014.07.037_bb0045","first-page":"57","article-title":"Fractures and vertebral bone mineral density in patients with renal osteodystrophy","volume":"30","author":"Piraino","year":"1988","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.bone.2014.07.037_bb0050","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0272-6386(99)70302-1","article-title":"Risk factors for vertebral fractures in renal osteodystrophy","volume":"33","author":"Atsumi","year":"1999","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.bone.2014.07.037_bb0055","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1097\/01.ASN.0000109671.99498.08","article-title":"Successful treatment of an adynamic bone disorder with bone morphogenetic protein-7 in a renal ablation model","volume":"15","author":"Lund","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.bone.2014.07.037_bb0060","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1681\/ASN.2004100835","article-title":"Low turnover osteodystrophy and vascular calcification are amenable to skeletal anabolism in an animal model of chronic kidney disease and the metabolic syndrome","volume":"16","author":"Davies","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.bone.2014.07.037_bb0065","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1093\/ndt\/gfh876","article-title":"Downregulation of parathyroid hormone receptor gene expression and osteoblastic dysfunction associated with skeletal resistance to parathyroid hormone in a rat model of renal failure with low turnover bone","volume":"20","author":"Iwasaki-Ishizuka","year":"2005","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.bone.2014.07.037_bb0070","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1038\/339538a0","article-title":"Transgenic mice with inducible dwarfism","volume":"339","author":"Borrelli","year":"1989","journal-title":"Nature"},{"key":"10.1016\/j.bone.2014.07.037_bb0075","doi-asserted-by":"crossref","first-page":"13835","DOI":"10.1073\/pnas.95.23.13835","article-title":"Dissociation between bone resorption and bone formation in osteopenic transgenic mice","volume":"95","author":"Corral","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.bone.2014.07.037_bb0080","doi-asserted-by":"crossref","first-page":"2698","DOI":"10.1073\/pnas.86.8.2698","article-title":"Thymidine kinase obliteration: creation of transgenic mice with controlled immune deficiency","volume":"86","author":"Heyman","year":"1989","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.bone.2014.07.037_bb0085","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1359\/jbmr.2001.16.12.2222","article-title":"Conditional ablation of the osteoblast lineage in Col2.3deltatk transgenic mice","volume":"16","author":"Visnjic","year":"2001","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bone.2014.07.037_bb0090","doi-asserted-by":"crossref","first-page":"3258","DOI":"10.1182\/blood-2003-11-4011","article-title":"Hematopoiesis is severely altered in mice with an induced osteoblast deficiency","volume":"103","author":"Visnjic","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.bone.2014.07.037_bb0095","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/jbmr.1805","article-title":"Standardized nomenclature, symbols, and units for bone histomorphometry: a 2012 update of the report of the ASBMR Histomorphometry Nomenclature Committee","volume":"28","author":"Dempster","year":"2013","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bone.2014.07.037_bb0100","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1002\/jbmr.5650020617","article-title":"Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee","volume":"2","author":"Parfitt","year":"1987","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bone.2014.07.037_bb0105","doi-asserted-by":"crossref","first-page":"337","DOI":"10.2307\/2534021","article-title":"Analysis of compositional bone density data using log ratio transformations","volume":"54","author":"Bracci","year":"1998","journal-title":"Biometrics"},{"key":"10.1016\/j.bone.2014.07.037_bb0110","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/8756-3282(93)90081-K","article-title":"Basic biomechanical measurements of bone: a tutorial","volume":"14","author":"Turner","year":"1993","journal-title":"Bone"},{"key":"10.1016\/j.bone.2014.07.037_bb0115","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.bone.2003.08.006","article-title":"Association between fluoride, magnesium, aluminum and bone quality in renal osteodystrophy","volume":"34","author":"Ng","year":"2004","journal-title":"Bone"},{"key":"10.1016\/j.bone.2014.07.037_bb0120","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1016\/j.bone.2006.06.025","article-title":"The 3.6kb DNA fragment from the rat Col1a1 gene promoter drives the expression of genes in both osteoblast and osteoclast lineage cells","volume":"39","author":"Boban","year":"2006","journal-title":"Bone"},{"key":"10.1016\/j.bone.2014.07.037_bb0125","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.semnephrol.2009.01.005","article-title":"Bone histomorphometry in renal osteodystrophy","volume":"29","author":"Ott","year":"2009","journal-title":"Semin Nephrol"},{"key":"10.1016\/j.bone.2014.07.037_bb0130","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s11914-007-0014-0","article-title":"Over-suppression of bone turnover: does it exist?","volume":"5","author":"Compston","year":"2007","journal-title":"Curr Osteoporos Rep"},{"key":"10.1016\/j.bone.2014.07.037_bb0135","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.bone.2011.07.017","article-title":"Issues in modern bone histomorphometry","volume":"49","author":"Recker","year":"2011","journal-title":"Bone"},{"key":"10.1016\/j.bone.2014.07.037_bb0140","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1210\/jc.2004-0952","article-title":"Severely suppressed bone turnover: a potential complication of alendronate therapy","volume":"90","author":"Odvina","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.bone.2014.07.037_bb0145","first-page":"18","article-title":"Bisphosphonates and low-impact femoral fractures: current evidence on alendronate-fracture risk","volume":"64","author":"Schneider","year":"2009","journal-title":"Geriatrics"},{"key":"10.1016\/j.bone.2014.07.037_bb0150","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1056\/NEJMoa1010650","article-title":"Bisphosphonate use and atypical fractures of the femoral shaft","volume":"364","author":"Schilcher","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bone.2014.07.037_bb0155","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1002\/jbmr.253","article-title":"Atypical subtrochanteric and diaphyseal femoral fractures: report of a task force of the American Society for Bone and Mineral Research","volume":"25","author":"Shane","year":"2010","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bone.2014.07.037_bb0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jbmr.1998","article-title":"Atypical subtrochanteric and diaphyseal femoral fractures: second report of a task force of the American Society for Bone and Mineral Research","volume":"29","author":"Shane","year":"2014","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bone.2014.07.037_bb0165","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1177\/039139880302600304","article-title":"Radial bone mineral density in hemodialysis patients with adynamic bone disease","volume":"26","author":"Nakashima","year":"2003","journal-title":"Int J Artif Organs"},{"key":"10.1016\/j.bone.2014.07.037_bb0170","first-page":"538","article-title":"Effects of bisphosphonates on matrix mineralization","volume":"2","author":"Boivin","year":"2002","journal-title":"J Musculoskelet Neuronal Interact"},{"key":"10.1016\/j.bone.2014.07.037_bb0175","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S8756-3282(00)00376-8","article-title":"Alendronate increases bone strength by increasing the mean degree of mineralization of bone tissue in osteoporotic women","volume":"27","author":"Boivin","year":"2000","journal-title":"Bone"},{"key":"10.1016\/j.bone.2014.07.037_bb0180","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S8756-3282(01)00485-9","article-title":"Alendronate increases degree and uniformity of mineralization in cancellous bone and decreases the porosity in cortical bone of osteoporotic women","volume":"29","author":"Roschger","year":"2001","journal-title":"Bone"},{"key":"10.1016\/j.bone.2014.07.037_bb0185","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1016\/j.bone.2007.01.012","article-title":"The bone mineralization density distribution as a fingerprint of the mineralization process","volume":"40","author":"Ruffoni","year":"2007","journal-title":"Bone"},{"key":"10.1016\/j.bone.2014.07.037_bb0190","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S8756-3282(00)00284-2","article-title":"Does suppression of bone turnover impair mechanical properties by allowing microdamage accumulation?","volume":"27","author":"Hirano","year":"2000","journal-title":"Bone"},{"key":"10.1016\/j.bone.2014.07.037_bb0195","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1210\/jcem.86.4.7436-1","article-title":"Fractures after long-term alendronate therapy","volume":"86","author":"Ott","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.bone.2014.07.037_bb0200","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/S8756-3282(01)00414-8","article-title":"Effects of suppressed bone turnover by bisphosphonates on microdamage accumulation and biomechanical properties in clinically relevant skeletal sites in beagles","volume":"28","author":"Mashiba","year":"2001","journal-title":"Bone"},{"key":"10.1016\/j.bone.2014.07.037_bb0205","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1359\/jbmr.2000.15.4.613","article-title":"Suppressed bone turnover by bisphosphonates increases microdamage accumulation and reduces some biomechanical properties in dog rib","volume":"15","author":"Mashiba","year":"2000","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bone.2014.07.037_bb0210","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/j.bone.2006.04.028","article-title":"Alterations in canine vertebral bone turnover, microdamage accumulation, and biomechanical properties following 1-year treatment with clinical treatment doses of risedronate or alendronate","volume":"39","author":"Allen","year":"2006","journal-title":"Bone"},{"key":"10.1016\/j.bone.2014.07.037_bb0215","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.bone.2010.10.159","article-title":"Bisphosphonate effects on bone turnover, microdamage, and mechanical properties: what we think we know and what we know that we don't know","volume":"49","author":"Allen","year":"2011","journal-title":"Bone"},{"key":"10.1016\/j.bone.2014.07.037_bb0220","first-page":"12","article-title":"Mineralization, microdamage, and matrix: how bisphosphonates influence material properties of bone","volume":"4","author":"Allen","year":"2007","journal-title":"BoneKEy"},{"key":"10.1016\/j.bone.2014.07.037_bb0225","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1359\/jbmr.070720","article-title":"Three years of alendronate treatment results in similar levels of vertebral microdamage as after one year of treatment","volume":"22","author":"Allen","year":"2007","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bone.2014.07.037_bb0230","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1359\/jbmr.2003.18.3.512","article-title":"Long-term treatment of incadronate disodium accumulates microdamage but improves the trabecular bone microarchitecture in dog vertebra","volume":"18","author":"Komatsubara","year":"2003","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bone.2014.07.037_bb0235","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s00198-007-0451-8","article-title":"Changes in vertebral strength\u2013density and energy absorption\u2013density relationships following bisphosphonate treatment in beagle dogs","volume":"19","author":"Allen","year":"2008","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.bone.2014.07.037_bb0240","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1007\/s00198-008-0754-4","article-title":"Changes in non-enzymatic glycation and its association with altered mechanical properties following 1-year treatment with risedronate or alendronate","volume":"20","author":"Tang","year":"2009","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.bone.2014.07.037_bb0245","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1002\/jor.22343","article-title":"Bisphosphonate-induced reductions in rat femoral bone energy absorption and toughness are testing rate-dependent","volume":"31","author":"Smith","year":"2013","journal-title":"J Orthop Res"},{"key":"10.1016\/j.bone.2014.07.037_bb0250","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1093\/gerona\/glt046","article-title":"The relevance of mouse models for investigating age-related bone loss in humans","volume":"68","author":"Jilka","year":"2013","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"10.1016\/j.bone.2014.07.037_bb0255","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1007\/s11357-012-9469-8","article-title":"Low levels of plasma IGF-1 inhibit intracortical bone remodeling during aging","volume":"35","author":"Courtland","year":"2013","journal-title":"Age (Dordr)"},{"key":"10.1016\/j.bone.2014.07.037_bb0260","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/jbmr.2007","article-title":"Dysapoptosis of osteoblasts and osteocytes increases cancellous bone formation but exaggerates cortical porosity with age","volume":"29","author":"Jilka","year":"2014","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bone.2014.07.037_bb0265","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S8756-3282(01)00623-8","article-title":"Aging and accumulation of microdamage in canine bone","volume":"30","author":"Frank","year":"2002","journal-title":"Bone"},{"key":"10.1016\/j.bone.2014.07.037_bb0270","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1746-160X-6-12","article-title":"The impact of bisphosphonates on the osteoblast proliferation and collagen gene expression in vitro","volume":"6","author":"Koch","year":"2010","journal-title":"Head Face Med"},{"key":"10.1016\/j.bone.2014.07.037_bb0275","first-page":"6001","article-title":"Bisphosphonates directly regulate cell proliferation, differentiation, and gene expression in human osteoblasts","volume":"60","author":"Reinholz","year":"2000","journal-title":"Cancer Res"},{"key":"10.1016\/j.bone.2014.07.037_bb0280","doi-asserted-by":"crossref","first-page":"6941","DOI":"10.1016\/j.biomaterials.2005.04.059","article-title":"Effects of bisphosphonates on proliferation and osteoblast differentiation of human bone marrow stromal cells","volume":"26","author":"von Knoch","year":"2005","journal-title":"Biomaterials"},{"key":"10.1016\/j.bone.2014.07.037_bb0285","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1056\/NEJMoa1001086","article-title":"Bisphosphonates and fractures of the subtrochanteric or diaphyseal femur","volume":"362","author":"Black","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bone.2014.07.037_bb0290","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1056\/NEJMc0707493","article-title":"Atypical fractures of the femoral diaphysis in postmenopausal women taking alendronate","volume":"358","author":"Lenart","year":"2008","journal-title":"N Engl J Med"}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328214003007?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328214003007?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,13]],"date-time":"2019-08-13T14:09:39Z","timestamp":1565705379000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S8756328214003007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11]]},"references-count":58,"alternative-id":["S8756328214003007"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2014.07.037","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2014,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development, validation and characterization of a novel mouse model of Adynamic Bone Disease (ABD)","name":"articletitle","label":"Article Title"},{"value":"Bone","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bone.2014.07.037","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}